This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Douillard, J. Y. Articles by Hoffman, T. Search for Related Content PubMed PubMed Citation Articles by Douillard, J. Y. Articles by Hoffman, T.

Monoclonal Antibodies to a Rat Colon Carcinoma: Model for Monoclonal Antibody Therapy of Solid Tumors

Laboratory of Cell Biology, Division of Blood and Blood Products [J. Y. D., J. L., C. B., T. H.], and Division of Product Quality Control, [J. R., I. L.] Center for Biologics Evaluation and Research, United States Food and Drug Administration, Bethesda, Maryland 20892, and The Wistar Institute, Philadelphia, Pennsylvania 19104 [H. B., S. B.A.]

Tumor progression, lung metastasis, and death occur in tumor-bearing BD IX syngeneic rats in a fashion similar to the course of patients with metastatic colon cancer. In an effort to establish a relevant model for monoclonal antibody (MoAb) therapy of tumors, we generated murine MoAb against DHD/TR, a dimethylhydrazine-induced rat colon carcinoma which has been adapted to cell culture. Murine MoAb 17B10 E4 (E4) reacts with the TR tumor and shows weak immunoperoxidase reactivity with normal rat tissues. Murine MoAb 5F7 D3 (D3) reacts with the tumor and a variety of normal rat epithelia. Both are IgG2a and mediate cytotoxicity by rat peripheral blood mononuclear cells. 18D5 F6 (F6) also reacts with the tumor and normal tissues but is an IgG2b and does not mediate cytotoxicity in the presence of rat effector cells. Iodinated E4 and D3 antibodies retained their immunoreactivity. E4 revealed 9.8 x 10⁵ antigenic sites per TR cell, with an affinity constant of 9.35 x 10⁷ M^-1, while D3 demonstrated 2.5 x 10⁶ antigenic sites and an affinity constant of 4.2 x 10⁷ M^-1. Immunoblotting showed that the antigens recognized by D3 and E4 are glycoproteins with molecular weights of 27,000 and 66,000, respectively. F6 failed to react with its antigen present in the blot. This rat colon carcinoma and the monoclonal antibodies described here may provide experimental data useful for implementing monoclonal antibodies in cancer therapy.

¹ Supported in part by Ligue Nationale Française Contre le Cancer, Paris, France, and Association Sainte Catherine, Avignon, France.

² Supported in part by Association pour la Recherche sur le Cancer (ARC), Villejuif, France.

³ Recipient of a fellowship from the Northwest Oncology Foundation, Seattle, WA.

⁴ To whom requests for reprints should be addressed.

Received 6/29/88. Revised 10/19/88. Accepted 11/ 1/88.

This article has been cited by other articles:

				D Masson, A Jarry, B Baury, P Blanchardie, C Laboisse, P Lustenberger, and M G Denis Overexpression of the CD155 gene in human colorectal carcinoma Gut, August 1, 2001; 49(2): 236 - 240. [Abstract] [Full Text] [PDF]